Related Experiment Video
Updated: Mar 26, 2026

04:41
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.6K
[GENETIC AND EPIGENETIC DETERMINANTS OF ALZHEIMER'S DISEASE]
Advances in Gerontology = Uspekhi Gerontologii
|February 10, 2016
Summary
Genetic and epigenetic factors significantly influence Alzheimer's disease (AD) risk and development. Polymorphisms in the APOE gene are key genetic risk factors for AD.
Area of Science:
- Neuroscience
- Genetics
- Epigenetics
Context:
- Alzheimer's disease (AD) presents a major global challenge.
- Genetic and epigenetic factors are increasingly recognized in AD etiology.
Purpose:
- To review recent research on genetic and epigenetic contributions to Alzheimer's disease.
- To discuss the role of specific gene variants, like APOE, in AD pathogenesis.
Summary:
- The review highlights studies linking genetic variations, particularly APOE polymorphisms, to increased AD risk.
- Epigenetic modifications are also discussed as crucial factors in the development and progression of Alzheimer's disease.
Impact:
- Understanding genetic and epigenetic factors is vital for developing targeted AD therapies.
- This knowledge advances the fields of neurodegenerative disease research and personalized medicine.
More Related Videos
Related Concept Videos
Human Genetics
1.9K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
108
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
108
Epigenetic Regulation
4.2K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.2K
Epigenetic Regulation
34.2K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K

